The food supply chain is subject to potential contamination with natural and industrial toxins. Food can contain pathogenic microorganisms, natural toxic compounds or industrial chemicals added intentionally or accidentally. While acute food poisoning is relatively rare, long-term effects of food toxins are an area of concern and, therefore, routine testing of foods at different stages of agrifood processes is legally required.
Toxin testing is typically carried out using analytic methods like high-performance liquid chromatography (HPLC) or liquid chromatography-mass spectrometry (LCMS), using commercially available standards, or immunological methods. Chemical and immunological analyses are very specific and typically detect a single analyte. Targeted LCMS also requires standards for the toxins under analysis.
The number of toxins with distinct chemistry, but similar toxicity, is often substantial. For example, there are 300 different known mycotoxins and 700 different pyrrolizidines. The related substances can be produced by the same pathogenic organism or by the metabolism of the toxin and may escape detection by normal analytical techniques. For some toxins, therefore, separate tests exist for the original and the metabolised toxin. Thus, it is impossible to test for such a wide range of mycotoxins using antibodies or LCMS.
Cell-based assays
Cell-based assays utilise whole cells as indicators of a specific biological process and can be used to detect chemicals which elicit toxicity. Cell-based assays can measure a variety of biological outcomes utilising parameters, including cell viability, transcriptional changes or signalling events involving protein-protein interactions. Cell-based analysis of signalling interactions can lead to the development of immunological tests, biochemical assays, and biosensors.
Cell-based assays are used in the pharmaceutical sector for pre-clinical screening of novel therapeutic compounds but have also been used for food toxicity testing. Examples include grain-borne mycotoxins, packaging-derived xenobiotics, shellfish toxins, or pyrrolizidine alkaloids in herbal extracts. Cell-based assays can simply measure cell viability (including toxicity or, conversely, growth stimulation by endocrine activity) but can also interrogate specific signalling events affected by toxins. Whole-cell bioassays based on bacterial cells, yeast and nematodes have been developed and are used for the detection of food and environmental toxins in some commercial settings. Cell-based assays can provide an alternative for and a complement to immunological and chemical testing. As for these established techniques toxin detection is influenced by food matrices.
The advantages of cell-based assays include:
- Automatic incorporation of bioavailability and viability testing.
- Ability to test for a group of chemicals with a similar toxicity profile.
- Ability to identify toxins for which no established standards currently exist.
- This is an active area of research, and the full potential of cell-based assays has not been fully realised yet.